Apixaban a better choice of drug than Rivarobaxan in Atrial Fibrillation- How?

There is an interesting research which states that apixaban is a much better drug of choice than Rivaroxaban in adults with atrial fibrillation (AF) on starting a direct oral anticoagulant (DOAC) for stroke prevention.
Atrial fibrillation incidence has increased in aged populations worldwide, and increased survival
with chronic diseases.
United States alone, reported atleast 3 to 6 million people have atrial
fibrillation, and the numbers are projected to reach 6 to 16 million by 2050 approximately. In
Europe, prevalent atrial fibrillation in 2010 was 9 million among individuals older than 55 years
and is expected to reach 14 million by 2060.
It is estimated that by 2050 atrial fibrillation will be diagnosed at least in 72 million individuals in Asia, approximately 3 million with atrial fibrillation related strokes.
Get the latest medical and heath news at medicaldialogues.in
Follow us on
Twitter: / medicaldialogs
Facebook: / medicaldialo. .
Instagram: / medicaldial. .
LinkedIn: / medi. .
Website: medicaldialogues.in/

[@bhaskarjha6629]

Mam, may I know if by using of apixaban if patients get some severe cause like ich and other they how it could be prevent in emergency cases